In the semaglutide group, no patients in STEP 3 or STEP 4 and 1% of patients in STEP 1 progressed to diabetes while in the placebo group, no patients in STEP 4, 1% of patients in STEP 3, and 3% of patients in STEP 1 progressed to diabetes
Cost and Accessibility: Both medications can be expensive, so consider insurance coverage and availability
Because people feel full longer, they eat less and lose weight
Mice were randomly assigned to treatment and control groups
In fact, modifying your dose without medical supervision could be dangerous risking underdosing or overdosing
After short-term repeated exposures, dominant lethals were induced in mice at intraperitoneal doses from 40 mg/kg body weight, given over a period of 3 months, 5 times per week (Lyarskii et al., 1983) and at vapour exposures from 460 mg/m 3 , for 6 h/day, 5 days per week, over 11 weeks (Generoso et al., 1983)